Latest News & Features
Americas
Scientist and patent attorney joins boutique IP firm in Philadelphia | Former in-house counsel brings expertise representing variety of life sciences clients. 25 July 2024
Americas
House of Representatives introduces bill to drive down cost of prescription drugs | Places “reasonable limit” on the number of patents a manufacturer can contest to prevent patent ‘thickets’ | Companion bill passed Senate earlier this month. 23 July 2024
Europe
Paris Central Division issues its first revocation judgment in dispute brought by Meril subsidiaries in Italy, Germany and India | Decision means infringement action by Edwards can resume at Munich Local Division | Damages worth €8m ($8.7m) | Gide, Marks & Clerk, Potter Clarkson among representatives. 23 July 2024
Americas
Commission upholds judge’s finding that Gator Bio did not infringe lab equipment patent | Sartorius sought to assert remaining patent-in-suit covering bio-layer interferometers. 18 July 2024
Europe
First patent filed using the new digital One IPO service | AI-powered internal tool to speed up the application process | Set for public launch in 2025 with a promise to “revolutionise” patent management. 18 July 2024
Americas
Guidance says use of AI in inventing does not affect how patent claims are assessed for eligibility | Emphasis placed on evaluating inventions themselves rather than the method of creation | Updates include new examples to assist examiners in evaluating AI-related patent claims. 18 July 2024
Big Pharma
New bill anticipated to depart from previous government’s light-touch approach to AI regulation | Attorneys fear “onerous or conflicting” requirements on pharma and biotech companies. 16 July 2024
Unified Patent Court
UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step. 16 July 2024
Careers
Firm adds new chair of Hatch-Waxman & Biologics Practice is an FDA and pharma litigation expert who will ‘provide clarity in an uncertain post-Chevron world’ | Shareholder brings extensive trial and appellate experience in automotive industry. 16 July 2024
Big Pharma
As the popularity of weight-loss drugs like Ozempic soars, the Danish company has to manage seasoned criminals and international investigations to get results, finds Marisa Woutersen. 12 July 2024